|
?:authorAffiliation
|
-
[\'Department of Medicine, Stanford University, Stanford, CA, USA. prasj@stanford.edu.\', \'Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA. prasj@stanford.edu.\', \'Department of Medicine, Stanford University, Stanford, CA, USA.\', \'Quantitative Sciences Unit, Stanford University, Stanford, CA, USA.\', \'Stanford Center for Clinical Research, Stanford University, Stanford, CA, USA.\', \'Department of Emergency Medicine, Stanford University, Stanford, CA, USA.\', \'Department of Pediatrics, Stanford University, Stanford, CA, USA.\', \'Eiger BioPharmaceuticals, Palo Alto, CA, USA.\', \'Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.\', \'Department of Genetics, Stanford University, Stanford, CA, USA.\', \'ChEM-H, Stanford University, Stanford, CA, USA.\', \'Department of Pathology, Stanford University, Stanford, CA, USA.\', \'Department of Medicine, Stanford University, Stanford, CA, USA. usingh@stanford.edu.\', \'Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA. usingh@stanford.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}